Possible role of opioids and KATP channels in neuroprotective effect of postconditioning in mice

Bharat Bhai Pateliya1, Nirmal Singh, Amteshwar Singh Jaggi

  • 1Department of Pharmaceutical Sciences and Drug Research, Punjabi University, Patiala, India.

Insights

Ischemic postconditioning, using opioids like morphine, protects the brain from injury caused by interrupted blood flow (ischemia and reperfusion). This protection involves opioid receptors and K(ATP) channels.

Area of Science:

  • Neuroscience
  • Pharmacology
  • Cardiovascular Research

Background:

  • Global cerebral ischemia and reperfusion (I/R) cause significant neuronal injury.
  • Postconditioning strategies are explored to mitigate I/R-induced damage.
  • The roles of opioids and K(ATP) channels in neuroprotection are not fully understood.

Purpose of the Study:

  • To investigate the neuroprotective mechanisms of ischemic and morphine postconditioning against global cerebral I/R injury.
  • To determine the involvement of opioid receptors and K(ATP) channels in these protective effects.

Main Methods:

  • Global cerebral ischemia was induced in mice via bilateral carotid artery occlusion, followed by reperfusion.
  • Ischemic postconditioning involved brief, repeated occlusions/reperfusions; morphine postconditioning used intravenous morphine.
  • Neuroprotection was assessed by infarct size (TTC staining) and behavioral tests (memory, motor coordination).
  • Opioid receptor antagonist (naloxone) and K(ATP) channel blocker (glibenclamide) were used to probe mechanisms.

Main Results:

  • I/R significantly increased infarct size and impaired memory and motor coordination.
  • Ischemic and morphine postconditioning markedly reduced I/R-induced neuronal injury and behavioral deficits.
  • Pretreatment with naloxone or glibenclamide diminished the neuroprotective effects of postconditioning.

Conclusions:

  • Ischemic and morphine postconditioning offer significant neuroprotection against global cerebral I/R injury.
  • Opioid receptors and K(ATP) channels are critical mediators of this neuroprotection.
  • Targeting these pathways may represent a therapeutic strategy for stroke and related conditions.